Increased sugar and lipid metabolism bring the risk of hyperlipidemia and fatty liver, especially the upregulation of MDH and HMG-CoA reductase, which is the marker enzyme of lipid metabolism in rat [36]. The gene discussed is HMGCR; the disease is hyperlipidemia.